United Therapeutics cleared for phase 1 trial of treprostinil-iloprost SMI

FDA clears United Therapeutics' phase 1 trial for treprostinil-iloprost SMI in pulmonary arterial hypertension.

CryptoAlerta — análise de criptomoedas e mercado em tempo real